Inivata raises $45 mln
Inivata Limited said Tuesday it completed a 31.5 million pound (US$45 million) Series A funding round. Existing investors Imperial Innovations, Cambridge Innovation Capital, and Johnson & Johnson Innovation - JJDC Inc. all participated in the round, as did new investor Woodford Patient Capital Trust. U.K.-based Inivata is a clinical cancer genomics company.
26 January 2016•6 mins read
